| |SEPTEMBER 20266VIVID OUTLOOKC ONT E NT SHow Biologics and Complex Therapies Are Reshaping CDMO StrategyTransforming API & Pharma Manufacturing with Next-Gen EHS TechnologiesIndia's Path to Billion-Dollar Drugs: Building a Strong EcosystemDriving Vaccine Adoption Beyond Pediatric Immunization in IndiaAkhil Ravi, CEO, Aurigene Pharmaceutical Services LimitedDr Kuber Jagdale, President - API Business Unit, Emcure Pharmaceutical Business FormationRehan Khan, Managing Director, MSD IndiaNilesh Pendse, Director - Vaccines, Pfizer IndiaAFTERWORDTHOUGHT CENTRAL1218243034Bridging Collaboration Gaps to Boost India's Pharma DiscoveryDr Sadhna Joglekar,Senior VP & Head - Global Drug Development India,Novartis15 Pharma Marketing KPIs Indian Companies Should Track in 202610ANALYSISCOVER STORY 14
< Page 5 | Page 7 >